Foresite Capital Fund V L.P. 13D/13G Filings for Cullinan Oncology, Inc. (CGEM)

Foresite Capital Fund V L.P. 13D and 13G filings for Cullinan Oncology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-11
3:05 pm
Sale		 2021-12-31 13G Cullinan Oncology, Inc.
CGEM		 Foresite Capital Fund V L.P. 1,524,008
3.500%		 -2,117,871decrease
(-58.15%)		 Filing
2021-01-15
06:05 am
Purchase		 2021-01-08 13G Cullinan Oncology, Inc.
CGEM		 Foresite Capital Fund V L.P. 3,641,879
8.800%		 3,641,879increase
(New Position)		 Filing